• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Glythera

edit

Creating a new generation of biological therapeutics through advanced glycosylation technologies

Glythera Limited is a young spin-out biotechnology company from the University of Bath with core expertise in protein/peptide functionalisation and glycosylation technologies, imparting improved pharmacokinetic properties to biological therapeutics.

Glythera successfully raised its first round of investment in 2008, with research operations being conducted in dedicated laboratories situated on the campus of the University of Bath

Recent Milestones

edit

• 
  Glythera received $3.14M (£2M) in Venture Round funding. (6/21/12)
  Posted 6/21/12 at 7:00pm via dowjones.com
• 
  Glythera received $793k (£500k) in Venture Round funding. (10/9/10)
  Posted 10/10/10 at 7:20pm via finsmes.com
• 
  Glythera added Tony Baxter as Chairman.
  Posted 10/10/10 at 7:20pm

Videos

Screenshots

edit

Sources

1. Glythera Receives Second Tranche of £500,000 Funding (finsmes.com) [edit]
2. U.K.'s Glythera Collects First Tranche of GBP2M Round (pevc.dowjones.com) [edit]